Could a thyroid hormone boost oxygen in severe lung failure?
NCT ID NCT04115514
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a thyroid hormone (T3) directly into the lungs can safely improve oxygen levels in adults with acute respiratory distress syndrome (ARDS), a severe lung condition. About 68 critically ill patients on ventilators will either receive the hormone or standard care. The goal is to see if T3 helps clear fluid and reduce inflammation in the lungs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS, HUMAN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
East Bank Hospital - M Health Fairview University of Minnesota Medical Center
Minneapolis, Minnesota, 55455, United States
-
M Health Fairview Southdale Hospital
Edina, Minnesota, 55435, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smartphone app speed up recovery after thyroid surgery?
- Why COVID-19 lungs fail: tiny blood vessel damage may be key
- Scientists probe why lung disease raises COVID-19 risk
- Watching a video before surgery may calm your nerves
- HIV Patients' thyroid health under the microscope
- Experimental cell treatment shows promise for COVID-19 lung failure